Suppr超能文献

肝癌。经门静脉进行经导管化疗栓塞的可能性。

Hepatic carcinoma. The possibility of transcatheter chemoembolization through the portal vein.

作者信息

Liu P C, Guo J Y, Hu G D, Huang Z C, Liu S C

机构信息

Department of Radiology, Tongji Hospital, Tongji Medical University, Wuhan.

出版信息

Chin Med J (Engl). 1991 Jul;104(7):543-7.

PMID:1908764
Abstract

A suspension of iodized oil and anticancer agent was injected into the portal veins of 20 rats with hepatic carcinoma and of 20 normal rats to observe its distribution in the liver and the effect on cancer tissue and normal cells. Microscopic and transmission electron microscopic examinations were carried out. Oil drops were seen in tumor cell lines, small blood vessels inside the cancer nest, the sinusoids, and the central veins. More oil drops were found in the peripheral parts of the tumor than in the central part. The distal small vessels were embolized with necrotic change of tumor cells and their subordinate normal liver cells. We conclude that portal vein part takes in the blood supply of liver cancer and tumor cell necrosis can be achieved after administration of iodized oil and anticancer agent mixture through the portal vein. Hence transcatheter treatment through the portal vein may be helpful as a supplement to intraarterial treatment of primary liver cancer and transcatheter embolization via the portal vein to reinforce the intraarterial therapy may be recommended. This procedure may cause necrosis of normal liver cells and care must be taken in clinical application.

摘要

将碘化油与抗癌剂的混悬液注入20只肝癌大鼠和20只正常大鼠的门静脉,观察其在肝脏内的分布以及对癌组织和正常细胞的影响。进行了显微镜和透射电子显微镜检查。在肿瘤细胞系、癌巢内的小血管、肝血窦和中央静脉中均可见油滴。肿瘤周边部分的油滴比中央部分更多。远端小血管发生栓塞,肿瘤细胞及其下属的正常肝细胞出现坏死改变。我们得出结论,门静脉部分参与肝癌的血供,经门静脉给予碘化油与抗癌剂混合物后可实现肿瘤细胞坏死。因此,经门静脉的介入治疗可作为原发性肝癌动脉内治疗的补充,推荐经门静脉进行经导管栓塞以加强动脉内治疗。此操作可能导致正常肝细胞坏死,临床应用时必须谨慎。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验